Reaction
Duodenal Obstruction reporting signals
As of the last recalculation, Duodenal Obstruction appears in 295 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is GEMCITABINE (PRR 32.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Gemcitabine | 17 | 32.2 | 32.3 |
| Gemcitabine Hydrochloride | 21 | 30.0 | 30.0 |
| Erlotinib Hydrochloride | 5 | 28.7 | 28.7 |
| Durvalumab | 7 | 24.8 | 24.9 |